On the recordSeptember 30, 2020
According to the non-partisan CBO, allowing the Federal Government to negotiate directly with drug companies could lower spending on brand name drugs by about $456 billion.
Source
congress.govEditor's note · Context
Raskin highlights potential savings from government negotiation with drug companies.
Share
More from Jamie Raskin
Jul 16, 2026
The story is that he continues to lie about it, and they’ve organized an entire political party, albeit a dwindling and shrinking one, around a lie.
Other voices in this conversation
